Armata Pharmaceuticals Inc
Statements
Cash Flow
Armata Pharmaceuticals Inc (ARMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -8.7 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.7 | -8.1 | -11 | -10 | -8.9 | -7.9 | -7.6 | -7.2 | -4.3 | -6.7 | -5.8 | -8.7 | -25 | |
| 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 1.6 | 2.9 | |
| -0.4 | 0.2 | 0.5 | 1.3 | 0.7 | 0.4 | 0.8 | 0.6 | 0.6 | 0.6 | 1.1 | 3.4 | 5.7 | |
| 0.1 | 0.6 | -1.7 | -0.7 | -0.9 | 1.2 | -1.2 | -2.0 | 1.8 | 0.0 | 0.9 | -2.9 | -0.2 | |
| 3.5 | 2.4 | 0.3 | 1.4 | 0.3 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | 0.4 | |
| -3.5 | -2.4 | -0.3 | -1.4 | -0.3 | 0.1 | -0.1 | -0.1 | -0.2 | -0.1 | -0.1 | 0.0 | -0.4 | |
| – | 0.0 | – | – | -0.1 | – | 0.0 | – | 0.0 | 0.0 | – | – | – | |
| – | – | – | – | 0.0 | 0.0 | 10 | 0.0 | 15 | 0.0 | 0.0 | – | – | |
| 25 | 0.0 | 35 | 0.1 | -0.1 | 0.0 | 10.0 | 0.0 | 15 | 0.7 | 0.6 | 28 | 44 | |
| 12 | -11 | 24 | -11 | -9.3 | -7.9 | 2.3 | -7.4 | 10 | -6.1 | -5.2 | 19 | 18 | |
| -13 | -11 | -11 | -12 | -9.2 | -7.9 | -7.7 | -7.4 | -4.5 | -6.7 | -5.8 | -8.7 | -26 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.